6YYN | pdb_00006yyn

Structure of Cathepsin S in complex with Compound 14


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.22 Å
  • R-Value Free: 
    0.217 (Depositor), 0.220 (DCC) 
  • R-Value Work: 
    0.158 (Depositor), 0.166 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 6YYN

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Highly Selective Sub-Nanomolar Cathepsin S Inhibitors by Merging Fragment Binders with Nitrile Inhibitors.

Schade, M.Merla, B.Lesch, B.Wagener, M.Timmermanns, S.Pletinckx, K.Hertrampf, T.

(2020) J Med Chem 63: 11801-11808

  • DOI: https://doi.org/10.1021/acs.jmedchem.0c00949
  • Primary Citation Related Structures: 
    6YYN, 6YYO, 6YYP, 6YYQ, 6YYR

  • PubMed Abstract: 

    Pharmacological inhibition of cathepsin S (CatS) allows for a specific modulation of the adaptive immune system and many major diseases. Here, we used NMR fragment screening and crystal structure-aided merging to synthesize novel, highly selective CatS inhibitors with picomolar enzymatic Ki values and nanomolar functional activity in human Raji cells. Noncovalent fragment hits revealed binding hotspots, while the covalent inhibitor structure-activity relationship enabled efficient potency optimization.


  • Organizational Affiliation
    • Grünenthal GmbH, Zieglerstr. 6, 52078 Aachen, Germany.

Macromolecule Content 

  • Total Structure Weight: 51.87 kDa 
  • Atom Count: 4,029 
  • Modeled Residue Count: 442 
  • Deposited Residue Count: 450 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Cathepsin SA [auth AAA],
B [auth BBB]
225Homo sapiensMutation(s): 0 
Gene Names: CTSS
EC: 3.4.22.27
UniProt & NIH Common Fund Data Resources
Find proteins for P25774 (Homo sapiens)
Explore P25774 
Go to UniProtKB:  P25774
PHAROS:  P25774
GTEx:  ENSG00000163131 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP25774
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
Q1E
(Subject of Investigation/LOI)

Query on Q1E



Download:Ideal Coordinates CCD File
E [auth AAA],
L [auth BBB]
~{N}-methyl-3-[4-([1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperazin-1-yl]sulfonyl-propanamide
C13 H19 N7 O3 S
KVLQRUOLMVHSTQ-UHFFFAOYSA-N
FLC

Query on FLC



Download:Ideal Coordinates CCD File
C [auth AAA],
D [auth AAA]
CITRATE ANION
C6 H5 O7
KRKNYBCHXYNGOX-UHFFFAOYSA-K
SO4

Query on SO4



Download:Ideal Coordinates CCD File
F [auth BBB]
G [auth BBB]
H [auth BBB]
I [auth BBB]
J [auth BBB]
F [auth BBB],
G [auth BBB],
H [auth BBB],
I [auth BBB],
J [auth BBB],
K [auth BBB]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
Binding Affinity Annotations 
IDSourceBinding Affinity
Q1E BindingDB:  6YYN Ki: 700 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.22 Å
  • R-Value Free:  0.217 (Depositor), 0.220 (DCC) 
  • R-Value Work:  0.158 (Depositor), 0.166 (DCC) 
Space Group: P 41 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 85.671α = 90
b = 85.671β = 90
c = 150.922γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
SCALAdata scaling
REFMACphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2021-05-12
    Type: Initial release
  • Version 1.1: 2022-11-23
    Changes: Database references, Derived calculations
  • Version 1.2: 2024-05-01
    Changes: Data collection, Refinement description
  • Version 1.3: 2024-11-13
    Changes: Structure summary